Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alterity Therapeutics Ltd (ATHE)

1.64   0 (0%) 03-03 17:00
Open: 1.64 Pre. Close: 1.64
High: 1.7099 Low: 1.62
Volume: 248,043 Market Cap: 57M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.711 - 1.724 1.724 - 1.733
Low: 1.598 - 1.611 1.611 - 1.62
Close: 1.624 - 1.643 1.643 - 1.658

Technical analysis

as of: 2021-03-03 4:36:34 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.49     One year: 2.90
Support: Support1: 1.57    Support2: 1.31
Resistance: Resistance1: 2.13    Resistance2: 2.48
Pivot: 1.85
Moving Average: MA(5): 1.65     MA(20): 1.88
MA(100): 1.65     MA(250): 1.42
MACD: MACD(12,26): -0.03     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 10.16     %D(3): 9.37
RSI: RSI(14): 43.08
52-week: High: 5.15  Low: 0.28  Change(%): 173.3
Average Vol(K): 3-Month: 72509  10-Days: 37186

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ATHE has closed above bottom band by 22.3%. Bollinger Bands are 10.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 26 Feb 2021
Alterity to present at the 7th International Congress of Multiple System Atrophy - PRNewswire

Thu, 25 Feb 2021
Alterity Therapeutics Ltd (ATHE) CEO David Stamler on Q2 2021 Results - Earnings Call Transcript - Seeking Alpha

Thu, 25 Feb 2021
Form 6-K ALTERITY THERAPEUTICS For: Dec 31 - StreetInsider.com

Tue, 09 Feb 2021
70 Stocks Moving In Tuesday's Mid-Day Session - Benzinga

Tue, 09 Feb 2021
50 Stocks Moving in Tuesday's Pre-Market Session - Benzinga

Tue, 09 Feb 2021
Here’s why the Alterity Therapeutics (ASX:ATH) share price blasted 20% higher today // The Motley Fool A ... - The Motley Fool Australia

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 34
Shares Float (M) 13
% Held by Insiders
% Held by Institutions 2.21
Shares Short (K) 99
Shares Short P. Month (K) 58

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin -296.16
Operating Margin
Return on Assets (ttm) -58.4
Return on Equity (ttm) -113.5
Qtrly Rev. Growth
Gross Profit (p.s.) -0.010
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.